Eckert & Ziegler (EUZ.DE) traded down -1.73 % during a 24 hours period ending at 04:00 PM Central Europe on Monday 26th. One Eckert & Ziegler stock can currently be bought for about EUR 13.1 on popular exchanges. Current supply of Eckert & Ziegler stocks is 62.6 mn. Eckert & Ziegler has a current market capitalization of EUR 817.9 mn and approximately EUR 876.3 k worth of Eckert & Ziegler was traded on exchanges in the last 24 hours. Since last month end, Eckert & Ziegler has traded 7.4 % up. Simple moving average of last 200 days is at EUR 14.39. The highest price of past 52 weeks was recorded at EUR 17.47 on 11/13/2025. 52 weeks low was at EUR 11.91 on 10/07/2026.

Here is how related stocks have performed in the past 24 hours:

  • Saf-holland (SFQ.DE) traded down -6.18 % and now trades at EUR 21.1. Current market capitalisation for Saf-holland is EUR 930.6 mn. Current price/earnings ratio for Saf-holland is 13.4.

  • Vincorion (V1NC.DE) traded down -2.63 % and now trades at EUR 19.14. Vincorion has a market capitalisation of EUR 925 mn.

  • Berliner Effektengesellschaf (BFV.F) traded flat 0 % and now trades at EUR 73. Berliner Effektengesellschaf has a market capitalisation of EUR 948 mn. Berliner Effektengesellschaf has a current price to earnings ratio of 34.2.

  • Thyssenkrupp Nucera & (NCH2.DE) traded up 0.46 % and now trades at EUR 7.98. Current market capitalisation for Thyssenkrupp Nucera & is EUR 972.6 mn. Thyssenkrupp’s newly independent materials‑trading arm, TK Accelis Group AG & Co KGaA, completed its spin‑off and initial public offering on the Frankfurt Stock Exchange. The move grants the company a separate legal and financial identity, with the parent holding a majority stake. Management highlighted that the separation will provide greater flexibility in capital deployment and a more autonomous funding structure, including a secured credit line tied to working‑capital assets. The company plans to use this independence to pursue growth, particularly in North America, and to improve its operating margin through expanded services and operational efficiencies. A temporary inclusion in the MDAX for a single trading day on 28 October ensures proper index representation during the transition. The spin‑off is part of Thyssenkrupp’s broader strategy to create a financial holding that allows its subsidiaries to operate more independently.

  • Jost Werke (JST.DE) traded down -1.32 % and now trades at EUR 60.1. Jost Werke has a market capitalisation of EUR 976.8 mn. Current price/earnings ratio for Jost Werke is 50.3.

About Eckert & Ziegler

The Eckert & Ziegler Strahlen- und Medizintechnik AG is a German company based in Berlin. It operates within the health care sector, focusing on manufacturing equipment for the pharmaceutical industry. Specifically, the company produces low-level radiation sources used to treat various diseases, including cancer, heart conditions, and other illnesses. Additionally, Eckert & Ziegler AG calibrates gamma cameras and positron emission computer tomographs using equipment they produce. Furthermore, they develop cancer drugs and market their products globally. Their website is www.ezag.de and they are listed on the Xetra stock exchange.